What did USFDA say about Granules India that's causing its shares to fall? | The Federal
The USFDA flagged six violations at Granules India’s Gagillapur facility, leading to a 21% drop in the company's shares and its inclusion in the F&O ban list. Key issues include unclean equipment, unresolved production discrepancies, repeat violations, inadequate quality control documentation, poor process evaluations, and lack of facility maintenance.
#granulesindia #sharemarket #usfda #pharmaceuticals
▶For more explainers, and interesting videos - thefederal.com/videos/
▶For the latest news and analysis - thefederal.com/
▶To watch The Federal's shows listed together for your easy access, click here: • The Federal Programmes
Follow The Federal News here -
▶Facebook: / thefederal.india
▶X: twitter.com/TheFederal_News
▶Instagram: instagram.com/thefederal_india/
▶LinkedIn: / thefederal
▶Whatsapp channel: https://www.whatsapp.com/channel/0029...
▶Threads: TheFederal India (@thefederal_india)
#BreakingNews #LatestNews #TodayNews #CurrentAffairs #News #IndiaNews #NewsToday #politics #exclusive #interviews #features
Download The Federal App here -
▶Android - http://bit.ly/TheFederalAndroid
▶iPhone - http://bit.ly/TheFederalios